11-47980997-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002843.4(PTPRJ):c.85C>T(p.Arg29Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000334 in 1,198,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000019 ( 0 hom. )
Consequence
PTPRJ
NM_002843.4 missense
NM_002843.4 missense
Scores
3
3
13
Clinical Significance
Conservation
PhyloP100: -0.476
Genes affected
PTPRJ (HGNC:9673): (protein tyrosine phosphatase receptor type J) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18078798).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRJ | NM_002843.4 | c.85C>T | p.Arg29Cys | missense_variant | 1/25 | ENST00000418331.7 | NP_002834.3 | |
PTPRJ | NM_001098503.2 | c.85C>T | p.Arg29Cys | missense_variant | 1/9 | NP_001091973.1 | ||
PTPRJ | XM_047427374.1 | c.427C>T | p.Arg143Cys | missense_variant | 1/17 | XP_047283330.1 | ||
PTPRJ | XM_017018085.2 | c.48+379C>T | intron_variant | XP_016873574.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPRJ | ENST00000418331.7 | c.85C>T | p.Arg29Cys | missense_variant | 1/25 | 1 | NM_002843.4 | ENSP00000400010 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000135 AC: 2AN: 147902Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
147902
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000190 AC: 2AN: 1050798Hom.: 0 Cov.: 33 AF XY: 0.00000403 AC XY: 2AN XY: 496168
GnomAD4 exome
AF:
AC:
2
AN:
1050798
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
496168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000135 AC: 2AN: 147902Hom.: 0 Cov.: 32 AF XY: 0.0000278 AC XY: 2AN XY: 72062
GnomAD4 genome
AF:
AC:
2
AN:
147902
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
72062
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 04, 2022 | The c.85C>T (p.R29C) alteration is located in exon 1 (coding exon 1) of the PTPRJ gene. This alteration results from a C to T substitution at nucleotide position 85, causing the arginine (R) at amino acid position 29 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;N;.;.
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;N;N;N
REVEL
Benign
Sift
Pathogenic
.;D;.;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D
Polyphen
0.98
.;D;.;.;.;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0171);Loss of MoRF binding (P = 0.0171);Loss of MoRF binding (P = 0.0171);Loss of MoRF binding (P = 0.0171);Loss of MoRF binding (P = 0.0171);Loss of MoRF binding (P = 0.0171);
MVP
MPC
0.81
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at